αB-Crystallin in clear cell renal cell carcinoma: Tumor progression and prognostic significance

Urologic Oncology: Seminars and Original Investigations

Volumn 31, Issue 7, 2013, Pages 1367-1377

  Ho, Pei Yin ^a   Chueh, Shih Chieh ^b   Chiou, Shyh Horng ^c   Wang, Shuo Meng ^d   Lin, Wei Chou ^e   Lee, I Liang ^f   Yang, Hsin Yi ^g   Peng, Hsiang Chi ^h   Lai, Ming Kuen ⁱ  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b LERNER RESEARCH INSTITUTE   (United States)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^f NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^g I SHOU UNIVERSITY   (Taiwan)

^h TAIPEI MEDICAL UNIVERSITY   (Taiwan)

ⁱ CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

B crystallin; Clear cell renal cell carcinoma; Drug resistance; Migration; Prognostic factor; Proliferation

Indexed keywords

ALPHA CRYSTALLIN; ALPHAB CRYSTALLIN; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG RESISTANCE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MALE; MIGRATION; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION;

CLEAR CELL RENAL CELL CARCINOMA; DRUG RESISTANCE; MIGRATION; PROGNOSTIC FACTOR; PROLIFERATION; ΑB-CRYSTALLIN;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-CRYSTALLIN B CHAIN; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CYCLIN A; DISEASE PROGRESSION; DRUG RESISTANCE, NEOPLASM; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROTEOMICS; SIROLIMUS;

EID: 84884672734     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2012.01.015     Document Type: Article

References (49)

1. Motzer R.J., Bander N.H., Nanus D.M. Renal-cell carcinoma. N Engl J Med 1996, 335:865-875.
2. Tomita Y. Early renal cell cancer. Int J Clin Oncol 2006, 11:22-27.
3. Reuter V.E., Presti J.C. Contemporary approach to the classification of renal epithelial tumors. Semin Oncol 2000, 27:124-137.
4. Bukowski R.M., Figlin R.A., Motzer R.J. Renal cell carcinoma: Molecular targets and clinical applications 2009, Springer Verlag.
5. Rini B.I., Atkins M.B. Resistance to targeted therapy in renal-cell carcinoma. Lancet Oncol 2009, 10:992-1000.
6. Takashi M., Katsuno S., Sakata T., et al. Different concentrations of two small stress proteins, αB crystallin and HSP27 in human urological tumor tissues. Urol Res 1998, 26:395-399.
7. Lowe J., McDermott H., Pike I., et al. αB crystallin expression in non-lenticular tissues and selective presence in ubiquitinated inclusion bodies in human disease. J Pathol 1992, 166:61-68.
8. Clark J.I., Muchowski P.J. Small heat-shock proteins and their potential role in human disease. Curr Opin Struct Biol 2000, 10:52-59.
9. Parcellier A., Schmitt E., Brunet M., et al. Small heat shock proteins HSP27 and αB-crystallin: Cytoprotective and oncogenic functions. Antioxid Redox Signal 2005, 7:404-413.
10. Sørlie T., Perou C.M., Tibshirani R., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001, 98:10869-10874.
11. Sotiriou C., Neo S.Y., McShane L.M., et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci U S A 2003, 100:10393-10398.
12. Mehlen P., Preville X., Chareyron P., et al. Constitutive expression of human hsp27, Drosophila hsp27, or human αB-crystallin confers resistance to TNF- and oxidative stress-induced cytotoxicity in stably transfected murine L929 fibroblasts. J Immunol 1995, 154:363-374.
13. Mineva I., Gartner W., Hauser P., et al. Differential expression of αB-crystallin and Hsp27-1 in anaplastic thyroid carcinomas because of tumor-specific αB-crystallin gene (CRYAB) silencing. Cell Stress Chaperones 2005, 10:171-184.
14. Gradishar W.J. The future of breast cancer: The role of prognostic factors. Breast Cancer Res Treat 2005, 89(Suppl):S17-S26.
15. Kamradt M.C., Lu M., Werner M.E., et al. The small heat shock protein αB-crystallin is a novel inhibitor of TRAIL-induced apoptosis that suppresses the activation of caspase-3. J Biol Chem 2005, 280:11059-11066.
16. Ivanov O., Chen F., Wiley E.L., et al. αB-crystallin is a novel predictor of resistance to neoadjuvant chemotherapy in breast cancer. Breast Cancer Res Treat 2008, 111:411-417.
17. Liu H.J., Lin P.Y., Lee J.W., et al. Retardation of cell growth by avian reovirus p17 through the activation of p53 pathway. Biochem Biophys Res Commun 2005, 336:709-715.
18. Lin S.Y., Chang Y.T., Liu J.D., et al. Molecular mechanisms of apoptosis induced by magnolol in colon and liver cancer cells. Mol Carcinog 2001, 32:73-83.
19. Sulochana K.N., Fan H., Jois S., et al. Peptides derived from human decorin leucine-rich repeat 5 inhibit angiogenesis. J Biol Chem 2005, 280:27935-27948.
20. Pilorget A., Annabi B., Bouzeghrane F., et al. Inhibition of angiogenic properties of brain endothelial cells by platelet-derived sphingosine-1-phosphate. J Cereb Blood Flow Metab 2005, 25:1171-1182.
21. Shi T., Dong F., Liou L.S., et al. Differential protein profiling in renal-cell carcinoma. Mol Carcinog 2004, 40:47-61.
22. Holcakova J., Hernychova L., Bouchal P., et al. Identification of αB-crystallin, a biomarker of renal cell carcinoma by SELDI-TOF MS. Int J Biol Markers 2008, 23:48-53.
23. Baldewijns MM, van Vlodrop IJ, Vermeulen PB, et al. VHL and HIF signalling in renal cell carcinogenesis. J Pathol;221:125-38.
24. Kroeze SG, Vermaat JS, van Brussel A, et al. Expression of nuclear FIH independently predicts overall survival of clear cell renal cell carcinoma patients. Eur J Cancer;46:3375-82.
25. Feng H., Stachura D.L., White R.M., et al. T-lymphoblastic lymphoma cells express high levels of BCL2, S1P1, and ICAM1, leading to a blockade of tumor cell intravasation. Cancer Cell 2010, 18:353-366.
26. LaCasse E.C., Baird S., Korneluk R.G., et al. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 1998, 17:3247-3259.
27. Li D.W., Liu J.P., Mao Y.W., et al. Calcium-activated RAF/MEK/ERK signaling pathway mediates p53-dependent apoptosis and is abrogated by αB-crystallin through inhibition of RAS activation. Mol Biol Cell 2005, 16:4437-4453.
28. King-Yin K., Boslooper A., Gao J., et al. The clinicopathological roles of αB-crystallin and p53 expression in patients with head and neck squamous cell carcinoma. Pathology 2008, 40:500-504.
29. Sitterding S.M., Wiseman W.R., Schiller C.L., et al. αB-crystallin: A novel marker of invasive basal-like and metaplastic breast carcinomas. Ann Diagn Pathol 2008, 12:33-40.
30. Moyano J.V., Evans J.R., Chen F., et al. αB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer. J Clin Invest 2006, 116:261-270.
31. Chin D., Boyle G.M., Williams R.M., et al. αB-crystallin, a new independent marker for poor prognosis in head and neck cancer. Laryngoscope 2005, 115:1239-1242.
32. Tang Q., Liu Y.F., Zhu X.J., et al. Expression and prognostic significance of the αB-crystallin gene in human hepatocellular carcinoma. Hum Pathol 2009, 40:300-305.
33. Bai F., Xi J.H., Wawrousek E.F., et al. Hyperproliferation and p53 status of lens epithelial cells derived from αB-crystallin knockout mice. J Biol Chem 2003, 278:36876-36886.
34. Ghosh J.G., Shenoy A.K., Clark J.I. Interactions between important regulatory proteins and human αB crystallin. Biochemistry 2007, 46:6308-6317.
35. Maddala R., Rao V.P. α-Crystallin localizes to the leading edges of migrating lens epithelial cells. Exp Cell Res 2005, 306:203-215.
36. Simpson NE, Lambert WM, Watkins R, et al. High levels of Hsp90 cochaperone p23 promote tumor progression and poor prognosis in breast cancer by increasing lymph node metastases and drug resistance. Cancer Res;70:8446-56.
37. Castilla C, Congregado B, Conde JM, et al. Immunohistochemical expression of Hsp60 correlates with tumor progression and hormone resistance in prostate cancer. Urology;76:e1011-1016.
38. Zoubeidi A., Zardan A., Wiedmann R.M., et al. Hsp27 promotes insulin-like growth factor-I survival signaling in prostate cancer via p90Rsk-dependent phosphorylation and inactivation of BAD. Cancer Res 2010, 70:2307-2317.
39. Liu W., Ma Y., Huang L., et al. Identification of HSP27 as a potential tumor marker for colorectal cancer by the two-dimensional polyacrylamide gel electrophoresis. Mol Biol Rep 2010, 37:3207-3216.
40. Samali A., Cotter T.G. Heat shock proteins increase resistance to apoptosis. Exp Cell Res 1996, 223:163-170.
41. Bubendorf L., Kolmer M., Kononen J., et al. Hormone therapy failure in human prostate cancer: Analysis by complementary DNA and tissue microarrays. J Natl Cancer Inst 1999, 91:1758-1764.
42. Cappello F., Rappa F., David S., et al. Immunohistochemical evaluation of PCNA, p53, HSP60, HSP10 and MUC-2 presence and expression in prostate carcinogenesis. Anticancer Res 2003, 23:1325-1331.
43. Thomas X., Campos L., Mounier C., et al. Expression of heat-shock proteins is associated with major adverse prognostic factors in acute myeloid leukemia. Leuk Res 2005, 29:1049-1058.
44. Whitesell L., Lindquist S.L. HSP90 and the chaperoning of cancer. Nat Rev Cancer 2005, 5:761-772.
45. Bansal H., Bansal S., Rao M., et al. Heat shock protein 90 regulates the expression of Wilms tumor 1 protein in myeloid leukemias. Blood 2010, 116:4591-4599.
46. Choi SH, Lee YJ, Seo WD, et al. Altered cross-linking of HSP27 by zerumbone as a novel strategy for overcoming HSP27-mediated radioresistance. Int J Radiat Oncol Biol Phys;79:1196-205.
47. Roue G., Perez-Galan P., Mozos A., et al. The Hsp90 inhibitor IPI-504 overcomes bortezomib resistance in mantle cell lymphoma in vitro and in vivo by down-regulation of the prosurvival ER chaperone BiP/Grp78. Blood 2011, 117:1270-1279.
48. Amato R.J. Chemotherapy for renal cell carcinoma. Semin Oncol 2000, 27:177-186.
49. Xu Q.Y., Gao Y., Liu Y., et al. Identification of differential gene expression profiles of radioresistant lung cancer cell line established by fractionated ionizing radiation in vitro. Chin Med J (Engl) 2008, 121:1830-1837.